Göker E, Lin J T, Trippett T, Elisseyeff Y, Tong W P, Niedzwiecki D, Tan C, Steinherz P, Schweitzer B I, Bertino J R
Department of Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Leukemia. 1993 Jul;7(7):1000-4.
We compared blast cells from adult and pediatric patients with untreated acute lymphoblastic leukemia (ALL) (as separated groups of T-lineage cell and B-lineage cell ALL) to determine if methotrexate (MTX) polyglutamate formation in adult patients might be a contributing cause to the known difference in clinical outcome, since MTX is a key drug in chemotherapy regimens. Adult B-lineage cell ALL blasts and blasts from the patients with T-lineage cell ALL accumulated lower amounts of total MTX and polyglutamates, especially long-chain MTX polyglutamates (glu3-6) than pediatric B-lineage cell ALL blasts. In view of the importance of polyglutamylation of MTX as a determinant of cytotoxicity of this drug, decreased formation of MTX polyglutamates is likely a contributing cause to the lower cure rate in adult ALL and T-lineage cell ALL as compared to childhood B-lineage cell ALL.
我们比较了成年和儿科未经治疗的急性淋巴细胞白血病(ALL)患者(作为T系细胞和B系细胞ALL的分组)的原始细胞,以确定成年患者中甲氨蝶呤(MTX)多聚谷氨酸的形成是否可能是导致已知临床结果差异的一个原因,因为MTX是化疗方案中的关键药物。与儿科B系细胞ALL原始细胞相比,成年B系细胞ALL原始细胞和T系细胞ALL患者的原始细胞积累的总MTX和多聚谷氨酸量较低,尤其是长链MTX多聚谷氨酸(glu3 - 6)。鉴于MTX多聚谷氨酰化作为该药物细胞毒性决定因素的重要性,MTX多聚谷氨酸形成减少可能是成年ALL和T系细胞ALL与儿童B系细胞ALL相比治愈率较低的一个原因。